中聯重科(000157.SZ):迪策鴻泰擬參與認購公司非公開發行的A股
格隆匯 1 月 13日丨中聯重科(000157.SZ)公佈,湖南迪策鴻泰投資合夥企業(有限合夥)(“迪策鴻泰”)擬參與認購公司非公開發行的A股股票。迪策鴻泰為公司持股5%以上股東湖南省國有資產監督管理委員會(“湖南省國資委”)控制的主體,此次交易構成關聯交易。
2021年1月13日,公司第六屆董事會2021年度第一次臨時會議審議通過了《關於公司關聯方擬參與認購公司非公開發行A股股票構成關聯交易的議案》,關聯董事賀柳回避表決。獨立董事對此次交易事項進行事前認可並發表了獨立意見。此次交易無須提交公司股東大會審議。
迪策鴻泰此次認購的金額不超過4億元人民幣,目前公司尚未就上述認購事宜與迪策鴻泰簽訂認購協議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.